Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
Freeline Therape last posted its earnings results on Tuesday, April 2nd, 2024. The company reported $-5.22 earnings per share for the quarter, missing analysts' consensus estimates of $-0.26 by $4.96. The company had revenue of 5.00 K for the quarter and had revenue of 0 for the year. Freeline Therape has generated $-23 earnings per share over the last year ($-22.52 diluted earnings per share) and currently has a price-to-earnings ratio of -0.29. Freeline Therape has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 09/29/2023 | Q3 2023 | N/A | -$2.77 | N/A | $771.25 K | $5.00 K |
| 06/30/2023 | Q2 2023 | N/A | -$3.69 | N/A | $617.00 K | $617.00 K |
| 03/31/2023 | Q1 2023 | N/A | $0.30 | N/A | N/A | $0 |
| 04/04/2023 | Q4 2022 | -$3.10 | -$5.31 | -2.21 | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$3.44 | N/A | N/A | $0 |
| 06/29/2022 | Q2 2022 | N/A | -$5.66 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | -$10.75 | -$9.40 | 1.35 | N/A | $0 |
| 03/31/2022 | Q4 2021 | -$10.75 | -$14.56 | -3.81 | N/A | $0 |
| 09/29/2021 | Q3 2021 | N/A | -$12.96 | N/A | N/A | $0 |
| 06/29/2021 | Q2 2021 | N/A | -$16.76 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | -$0.70 | -$14.70 | -14 | N/A | $0 |
| 03/31/2021 | Q4 2020 | -$0.70 | -$15.93 | -15.23 | N/A | $0 |
| 09/29/2020 | Q3 2020 | N/A | -$10.78 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$7.24 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | -$39.47 | N/A | N/A | $0 |
| 06/29/2019 | Q2 2019 | N/A | -$0.63 | N/A | N/A | $0 |
| 03/30/2019 | Q1 2019 | N/A | -$0.63 | N/A | N/A | $0 |
| 06/29/2018 | Q2 2018 | N/A | -$0.39 | N/A | N/A | $0 |
| 03/30/2018 | Q1 2018 | N/A | -$0.39 | N/A | N/A | $0 |
The conference call for Freeline Therape's latest earnings report can be listened to online.
The conference call transcript for Freeline Therape's latest earnings report can be read online.
Freeline Therape (:FRLN) has a recorded net income of $-88,972,000.Freeline Therape has generated $-22.52 earnings per share over the last four quarters.
Freeline Therape (:FRLN) has a price-to-earnings ratio of -0.29 and price/earnings-to-growth ratio is -0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED